Episode 18: Karen Petrou and David Brint - BioBonds

Episode 18 March 23, 2022 00:55:46
Episode 18: Karen Petrou and David Brint - BioBonds
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 18: Karen Petrou and David Brint - BioBonds

Mar 23 2022 | 00:55:46

/

Show Notes

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.

Other Episodes

Episode 45

December 12, 2024 00:37:26
Episode Cover

Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

"It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they...

Listen

Episode 31

June 20, 2023 00:44:32
Episode Cover

Episode 31: Pam Cusick, SVP, Rare Patient Voice

"What can I contribute that my doctor can't contribute? And that's a real 'a-ha' moment when we share with them how they're the experts...

Listen

Episode 43

September 12, 2024 00:39:18
Episode Cover

Episode 43: Isaac Stoner, Co-founder and CEO at Octagon Therapeutics

"I hope we're moving into the age of the generalist, where knowing how to learn and learning how to learn are more important than...

Listen